618 related articles for article (PubMed ID: 26607183)
21. Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach.
Horwitz SM; Olsen EA; Duvic M; Porcu P; Kim YH
J Natl Compr Canc Netw; 2008 Apr; 6(4):436-42. PubMed ID: 18433609
[TBL] [Abstract][Full Text] [Related]
22. The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
Vermeer MH; Nicolay JP; Scarisbrick JJ; Zinzani PL
Br J Dermatol; 2021 Jul; 185(1):19-25. PubMed ID: 33155285
[TBL] [Abstract][Full Text] [Related]
23. Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.
Vural S; Akay BN; Botsalı A; Atilla E; Parlak N; Okçu Heper A; Şanlı H
Turk J Haematol; 2018 Mar; 35(1):35-41. PubMed ID: 28533196
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous lymphomas: exploration of 10-year data from supraregional mutlidisciplinary team meetings in Glasgow, UK.
McCusker S; Ngu I
Clin Exp Dermatol; 2023 Aug; 48(9):1036-1039. PubMed ID: 37140442
[TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.
Berg S; Villasenor-Park J; Haun P; Kim EJ
Curr Hematol Malig Rep; 2017 Jun; 12(3):234-243. PubMed ID: 28540671
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
[TBL] [Abstract][Full Text] [Related]
27. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Hautarzt; 2019 Oct; 70(10):815-830. PubMed ID: 31511903
[TBL] [Abstract][Full Text] [Related]
28. [Cutaneous lymphomas : Clinical presentation - diagnosis - treatment].
Wobser M; Goebeler M
Pathologe; 2020 Feb; 41(1):79-94. PubMed ID: 31932947
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.
Bobrowicz M; Fassnacht C; Ignatova D; Chang YT; Dimitriou F; Guenova E
Int Arch Allergy Immunol; 2020; 181(10):733-745. PubMed ID: 32690848
[TBL] [Abstract][Full Text] [Related]
30. [Cutaneous T-cell lymphoma].
Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
[No Abstract] [Full Text] [Related]
31. Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.
Devata S; Wilcox RA
Am J Clin Dermatol; 2016 Jun; 17(3):225-37. PubMed ID: 26923912
[TBL] [Abstract][Full Text] [Related]
32. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
33. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
Whittaker SJ; Marsden JR; Spittle M; Russell Jones R; ;
Br J Dermatol; 2003 Dec; 149(6):1095-1107. PubMed ID: 14696593
[No Abstract] [Full Text] [Related]
34. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
Edelson RL
J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
[TBL] [Abstract][Full Text] [Related]
35. A new nail in the CTCL coffin.
Lessin SR
J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
[TBL] [Abstract][Full Text] [Related]
36. Mycosis fungoides and Sézary syndrome - Review and outlook.
Latzka J; Trautinger F
J Dtsch Dermatol Ges; 2023 Apr; 21(4):386-391. PubMed ID: 36971307
[TBL] [Abstract][Full Text] [Related]
37. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
38. Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma.
Trager MH; Geskin LJ
G Ital Dermatol Venereol; 2019 Dec; 154(6):681-695. PubMed ID: 31859467
[TBL] [Abstract][Full Text] [Related]
39. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
40. Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas.
Isufi I; Seropian S; Gowda L; Wilson LD; Roberts K; Girardi M; Perreault S; Foss F
Leuk Lymphoma; 2020 Dec; 61(12):2955-2961. PubMed ID: 32643494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]